Rañola, Nestor L.

HRN: 12-47-05  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2023
CEFTAZIDIME 1GM (VIAL)
08/19/2023
08/26/2023
IV
1.5
Q8H
CAP MR
Waiting Final Action 
08/25/2023
CEFTAZIDIME 1GM (VIAL)
08/25/2023
09/21/2023
IV
1 Gram
Q 8 Hours
Cap Mr
Waiting Final Action 
08/25/2023
AZITHROMYCIN 500MG TABLET (TAB)
08/25/2023
08/31/2023
PO
500 Mg
OD
Cap Mr
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: